BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27859058)

  • 1. A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events.
    Xu J; Fang Y; Qin J; Chen X; Liang X; Xie X; Lu W
    FEBS Lett; 2016 Dec; 590(24):4594-4605. PubMed ID: 27859058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
    Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
    Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of HPV16 E6* Alters β-Integrin and Mitochondrial Dysfunction Pathways in Cervical Cancer Cells.
    Evans W; Filippova M; Filippov V; Bashkirova S; Zhang G; Reeves ME; Duerksen-Hughes P
    Cancer Genomics Proteomics; 2016; 13(4):259-73. PubMed ID: 27365376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism.
    Paget-Bailly P; Meznad K; Bruyère D; Perrard J; Herfs M; Jung AC; Mougin C; Prétet JL; Baguet A
    Sci Rep; 2019 Apr; 9(1):5938. PubMed ID: 30976051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
    Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
    Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: A descriptive study in invasive cervical cancer.
    Brant AC; Menezes AN; Felix SP; de Almeida LM; Sammeth M; Moreira MAM
    Genomics; 2019 Dec; 111(6):1853-1861. PubMed ID: 30552977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
    Harden ME; Munger K
    Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
    Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the
    Chen X; Loo JX; Shi X; Xiong W; Guo Y; Ke H; Yang M; Jiang Y; Xia S; Zhao M; Zhong S; He C; Fu L; Li F
    Cancer Res; 2018 Mar; 78(6):1418-1430. PubMed ID: 29339538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
    Morel A; Baguet A; Perrard J; Demeret C; Jacquin E; Guenat D; Mougin C; Prétet JL
    Oncotarget; 2017 Jul; 8(28):46163-46176. PubMed ID: 28521287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.
    Smith SP; Scarpini CG; Groves IJ; Odle RI; Coleman N
    Sci Rep; 2016 Jul; 6():29832. PubMed ID: 27457222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiles are altered in human papillomavirus-16 E6 D25E-expressing cell lines.
    Jang M; Rhee JE; Jang DH; Kim SS
    Virol J; 2011 Sep; 8():453. PubMed ID: 21943319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
    Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
    Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
    Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
    Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
    Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
    Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.